Lv63
2380 积分 2023-06-05 加入
Brief Report: Low Delta-Like Ligand 3 Expression and T-Cell Exhaustion Drive Resistance to Tarlatamab Combined With Anti–Programmed Cell Death Protein 1 in SCLC
2个月前
已关闭
1193: SEPSIS: IS IT TIME TO LEAVE SIRS BEHIND? A SYSTEMATIC REVIEW AND META-ANALYSIS OF SEPSIS DEFINITIONS
3个月前
已关闭
SIRS, SOFA, qSOFA, and NEWS in the diagnosis of sepsis and prediction of adverse outcomes: a systematic review and meta-analysis
3个月前
已完结
Rheumatoid Arthritis: Pathogenesis, Therapeutic Strategies, Advances, and Structural Activity Relationships of Synthesized Agents
5个月前
已完结
Immune checkpoint inhibitors and rheumatoid arthritis: All roads lead to PD-1?
5个月前
已完结
A Phase 2 Trial of Peresolimab for Adults with Rheumatoid Arthritis
5个月前
已完结
GenSci120, a humanized PD-1 agonistic monoclonal antibody, enhances the binding of both PD-L1 and PD-L2 to PD-1, and mitigates the symptoms of GVHD in a mouse model
7个月前
已完结
BL-B01D1, a first-in-class EGFR–HER3 bispecific antibody–drug conjugate, in patients with locally advanced or metastatic solid tumours: a first-in-human, open-label, multicentre, phase 1 study
11个月前
已完结
Targeted therapy and drug resistance in triple-negative breast cancer: the EGFR axis
1年前
已完结
皖公网安备34019202002308
